Technical Analysis for ABBV - AbbVie Inc.

Grade Last Price % Change Price Change
grade A 96.3 -0.18% -0.17
ABBV closed down 0.18 percent on Tuesday, December 12, 2017, on 80 percent of normal volume.
Track This Stock
Watchlist Portfolio
Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical ABBV trend table...

Date Alert Name Type % Chg
Dec 12 BB Squeeze Ended Range Expansion 0.00%
Dec 12 Wide Bands Range Expansion 0.00%
Dec 11 Bollinger Band Squeeze Range Contraction -0.18%
Dec 11 NR7 Range Contraction -0.18%
Dec 11 BB Squeeze + Upper Band Touch Range Contraction -0.18%
Dec 11 Wide Bands Range Expansion -0.18%
Dec 11 Upper Bollinger Band Touch Strength -0.18%
Dec 8 Bollinger Band Squeeze Range Contraction 0.36%
Dec 8 Wide Bands Range Expansion 0.36%
Dec 8 Gapped Up Strength 0.36%

Older signals for ABBV ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
Basic chart:

Profile
AbbVie Inc., a research-based biopharmaceutical company, engages in the discovery, development, manufacture, and sale of pharmaceutical products worldwide. Its product portfolio includes a range of adult and pediatric pharmaceuticals, including HUMIRA, a biologic therapy administered as a subcutaneous injection to treat various autoimmune diseases; Synthroid used in the treatment of hypothyroidism; AndroGel, a daily testosterone replacement therapy; Creon, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Kaletra, a prescription anti-HIV-1 medicine used with other anti-HIV-1 medications to increase the chance of treatment response in people with HIV-1; and Lupron, a product for the palliative treatment of advanced prostate cancer. The company also offers TriCor and TRILIPIX, which are fibric acid derivatives that are indicated as adjuncts to diet to reduce total cholesterol, LDL cholesterol, and triglyceride levels; Niaspan, an extended release form of niacin that is indicated as an adjunct to diet to reduce total cholesterol, LDL cholesterol, and triglyceride levels, as well as to increase HDL cholesterol levels; Synagis, which protects at-risk infants from severe respiratory disease or respiratory syncytial virus; Sevoflurane, an anesthesia product for human use; Duodopa, a levodopa-carbidopa intestinal gel used to treat advanced Parkinson's disease; and Zemplar used for the prevention and treatment of secondary hyperparathyroidism. It sells its products to wholesalers, distributors, government agencies, health care facilities, specialty pharmacies, and independent retailers from its distribution centers and public warehouses. The company has collaboration with Alvine Pharmaceuticals, Inc. to develop a oral treatment for patients with celiac disease. AbbVie Inc. was incorporated in 2012 and is based in North Chicago, Illinois. As of January 01, 2013.AbbVie Inc. operates independently of Abbott Laboratories.
Is ABBV a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 98.52
52 Week Low 57.7604
Average Volume 5,272,569
200-Day Moving Average 75.7191
50-Day Moving Average 93.4299
20-Day Moving Average 95.0945
10-Day Moving Average 95.705
Average True Range 1.9873
ADX 12.19
+DI 23.33
-DI 22.11
Chandelier Exit (Long, 3 ATRs ) 92.5581
Chandelier Exit (Short, 3 ATRs ) 98.6719
Upper Bollinger Band 97.0261
Lower Bollinger Band 93.1629
Percent B (%b) 0.81
BandWidth 4.062485
MACD Line 0.8418
MACD Signal Line 0.9308
MACD Histogram -0.0889
Fundamentals Value
Market Cap 153.52 Billion
Num Shares 1.59 Billion
EPS 4.07
Price-to-Earnings (P/E) Ratio 23.66
Price-to-Sales 5.35
Price-to-Book 23.76
PEG Ratio 1.00
Dividend 2.56
Dividend Yield 2.66%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 99.20
Resistance 3 (R3) 99.00 97.85 98.71
Resistance 2 (R2) 97.85 97.11 97.94 98.55
Resistance 1 (R1) 97.07 96.65 96.50 97.27 98.39
Pivot Point 95.92 95.92 95.63 96.01 95.92
Support 1 (S1) 95.14 95.18 94.57 95.34 94.21
Support 2 (S2) 93.99 94.72 94.08 94.05
Support 3 (S3) 93.21 93.99 93.89
Support 4 (S4) 93.41